Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of PGL4001 (Ulipristal) Versus Placebo for Pre-Operative Treatment of Symptomatic Uterine Myomas

NCT00755755 is registered in ClinicalTrials.gov with PregLem SA as lead sponsor.

NCT NCT00755755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00755755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of PGL4001 (Ulipristal) Versus Placebo for Pre-Operative Treatment of Symptomatic Uterine Myomas
Lead sponsor
PregLem SA
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2008
Completion date
August 31, 2010
Enrollment
241 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

uterine myomas